SLC company uses artificial intelligence to aid in drug discovery KSL.com

Salt Lake City-based company Recursion Pharmaceuticals was recognized Tuesday for its drug discovery platform, which combines both the innovation of artificial intelligence and the mystery of experimental biology. Recursion Pharmaceuticals received two Fierce Innovation awards from the biotech and pharmaceutical industries as recognition for their platform, which is said to increase the rate at which drugs can be discovered. "Traditional drug discovery can take more than a decade and billions of dollars per approved compound," Recursion's co-founder and CEO, Chris Gibson, said in a news release. "Recursion's platform can radically increase the scale at which drugs are discovered, saving years of development time and the associated costs." The platform uses tons of microscopic pictures of human cells, including diseased cells and cells that have been treated with different chemicals and drugs, and utilizes image recognition to identify which parts of the cell change when afflicted with a disease or treated with a drug.